This study was aimed to reveal the clinical features,natural history of the diseases and current therapeutic situations of cerebral venous thrombosis (CVT) in China mainland. Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Death rate
Timeframe: 1 year from baseline
Functional independence
Timeframe: 1 year from baseline
Recurrence of cerebral venous sinus thrombosis, deep cerebral venous thrombosis and cortical vein thrombosis
Timeframe: 1 year from baseline
Incidence of hemorrhagic complication
Timeframe: 1 year from baseline
Incidence of sinus wall rupture
Timeframe: 1 year from baseline
Incidence of acute ischemic stroke
Timeframe: 1 year from baseline
Incidence of acute myocardial infarction
Timeframe: 1 year from baseline
Incidence of pulmonary embolism
Timeframe: 1 year from baseline
Incidence of deep venous thrombosis
Timeframe: 1 year from baseline